This website uses its own and third party technical cookies, solely to ensure enhanced navigation and to gather anonymous statistical navigation data without any user profiling.

If you wish to learn more or deny consent to all or some cookies click here.

If you access any element below this banner you automatically consent to the use of cookies.


Tradition becomes future

Few Italian companies can boast the successes of Abiogen Pharma in the Chemical and Pharmaceutical field.

The Company’s roots lie in Pisa at the beginning of the last century when Commendatore Alfredo Gentili, my great-grandfather, founded Istituto Galenico which later became Istituto Gentili S.p.A.
The purchase of Istituto Gentili S.p.A. by the American multinational Company Merck Sharp & Dohme in 1997, opened a path for the creation of Abiogen Pharma, which having maintained most of the product list, staff and site of Istituto Gentili, was launched onto the Italian and international market with the skills and professionalism acquired in over ninety years of activity in the field.

Abiogen Pharma embodies the dreams, projects and targets that had been the inspiration of Alfredo Gentili since 1917. In today’s national pharmaceutical panorama, it represents a family business tradition matured through four generations, with a wealth of scientific and technological knowledge that are the strengths of a Company whose ambition is to combine the Italian model of a medium-sized enterprise with a modern, flexible and innovative Company.

Massimo Di Martino

President and Managing Director

Abiogen Pharma